Louisiana State University Health Sciences Center Shreveport
54
3
8
31
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
25.9%
14 terminated/withdrawn out of 54 trials
68.9%
-17.6% vs industry average
6%
3 trials in Phase 3/4
42%
13 of 31 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (54)
Effect of Rapid Heat Stress on Firefighters Musculoskeletal Injury Risk
Role: lead
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
Role: collaborator
LearningRx Cognitive Training for Brain Injury
Role: collaborator
STaR Trial: Multiple Ligament Knee Injuries
Role: collaborator
Gluteal Activation Plus Movement Retraining
Role: lead
Impact of the Wingate Test on Post-activation Potentiation
Role: lead
Fomepizole Dosing During Continuous Renal Replacement Therapy (CRRT)
Role: collaborator
International PPB/DICER1 Registry
Role: collaborator
The PRIME-CRC Trial to Promote CRC Screening in Rural Communities
Role: lead
Effect of Sequencing on Outcome Measures
Role: lead
Impact of Hip Activation Compared to Hip Plus Balance Training on the Forward-Step-Down Test
Role: lead
Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Syndrome and Associated Gait Changes in Post-menopausal Women
Role: lead
Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
Role: lead
Hip Activation vs. Hip Activation + Core Stabilization
Role: lead
Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations
Role: lead
Improving Prescription Drug Warning Labels
Role: collaborator
Promoting Successful Weight Loss in Primary Care in Louisiana
Role: collaborator
Optimization of Blood Levels of 25(OH)-Vitamin D in African Americans
Role: lead
Hip Activation and FSDT
Role: lead
Plasma Hydrogen Sulfide as a Biomarker for Alzheimer's Disease and Related Dementias
Role: lead